Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -37.02 | 20.39 |
| PEG Ratio (TTM) | -1.45 | 15.94 |
| P/S Ratio (TTM) | 1.19 | 7.09 |
| P/B Ratio (TTM) | 2.61 | 5.96 |
| P/FCF Ratio (TTM) | 18.51 | 16.85 |
| Price to 5YR AVG Earnings Ratio | -13.04 | 109.59 |
| Price to 5YR AVG FCF Ratio | -302.37 | 38.41 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -3.01% | 1.28% |
| ROE (TTM) | -6.98% | 8.68% |
| Net Profit Margin (TTM) | -3.16% | 4.95% |
| ROIC 5YR AVG | -4.98% | 11.87% |
Growth (63%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 27.72% | -120.22% | -145.56% |
| Revenue | 8.49% | 14.86% | 27.75% |
| Net Income | 37.95% | -132.92% | -172.99% |
| Cash Flow | 2,360.86% | 98.09% | 299.72% |
Health (23%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.08 | 2.49 |
| Quick Ratio (TTM) | 1.08 | 2.31 |
| D/E Ratio (TTM) | 0.75 | 0.72 |
| Interest Coverage (TTM) | -0.62 | 6.58 |
| Piotroski F-Score | 3 | 5 |
| Altman Z-Score | 1.66 | 7.57 |
| LTL to 5YR AVG FCF | -68.74 | 2.13 |
| Shares Outstanding Growth 5YR AVG | 7.71% | 4.82% |